SlideShare a Scribd company logo
1 of 68
patient
with
hyperte
nsion
Nursing management of patient
with hypertension
Blood pressure
 In normal circulation, pressure is exerted by the flow of
blood through the heart and blood vessels. It is the
product of cardiac output multiplied by peripheral
resistance. Normal blood pressure at rest is within the
range of 100-140mmHg systolic (top reading) and 60-
90mmHg diastolic .
Determinants of BP and regulation
 These are the fundamental factors which determine
the value of BP. They are
 1. Cardiac output
 2.peripheral vascular resistance
These are also called as factors controlling BP.
 BP= cardiac output X PVR
Regulatory mechanisms
 Short term: Short term regulations are achieved by
neural regulations where as long term regulations are
achieved by controlling blood volume and Na retension
via renal mechanisms.
 Nervous System Control :BP by changing blood
distribution in the body and by changing blood vessel
diameter. Sympathetic & Parasympathetic activity will
affects veins, arteries & heart to control HR and force of
contraction
 Baroreceptors :Baroreceptors are stretch receptors found
in the carotid body, aortic body and the wall of all large
arteries of the neck and thorax. Baroreceptors entered
the medululla Secondary signals inhibit the
vasoconstrictor center of medulla and excite the vagal
parasympathetic center effect vasodilatation of the veins
and arterioles decreased heart rate and strength of heart
contractiont herefore, causes arterial pressure to
decrease (as decrease in PR and CO) Conversely, low
pressure has opposite effects,reflexly causing the
pressure rise back to normal
 Increased Parasympathetic Activity: Effect of
increased parasympathetic and decreased sympathetic
activity on heart and blood pressure: Increased activity
of vagus (parasympathetic) nerve .
 Decreased activity of sympathetic cardiac Nerves
Reduction of heart rate .Lower cardiac output .Lower
blood pressure
Long term
 long term control is achieved by adjusting the blood
volume and lowering Ca concentration in the VSM.
 Hormones :1)ADH reduces water excreation and
causes water conservation.2) Renin ultimately cause
production of angiotensin II causes aldosterone
production which leads to the water and sodium
retension.
 ANP:released when atria are stretched . it causes
dieresis and reduce blood volume and BP.
 .
 Role of Ca ions in the VSM : Its accumulation causes
rise in the vascular tone and increases the vascular
tone
 Endocrine system: stimulation of SNS results in
release of epinephrine along with small fraction of nor
epinephrine by adrenal medulla. epinephrine increases
CO by increasing HR and myocardial contractility
Factors affecting BP
 A. PHYSIOLOGICAL
 Age :tends to increase in elder people.
 Sex:before the onset of menopause women have little lower BP
than that of males of same age group.after menopause women
have little higher BP than that of males.
 Meals: after meals BP is higher.
 Emotion: range and panic may rise BP.
 Exposure to cold : increase BP.inorder to preserve body
heat,body tries to keep temperature by Cutaneous vaso
constriction as a result of SNS stimulation.
 Excercise
 Sleep:cause fall of BP.
 Circardian rhythm: BPis highest in the morning and least in
the night.
 B. PATHOLOGICAL
 Clinical conditions alter BP include renal artery
senosis, pheochromacytoma and pre eclampsia
 Drug induced: sympathetic stimulants like
adrenalin,nor adrenalin, andphenylephrine rise BP,
while vascular smooth muscle relaxants like
hydralazine reduces BP.
Hypertension- definition
 Hypertension is defined by the Seventh Report of the
Joint National Committee on Prevention, Detection,
Evaluation, and Treatment of High Blood Pressure (JNC
7) as a systolic blood pressure greater than 140 mm Hg
and a diastolic pressure greater than 90 mm Hg based
on the average of two or more accurate blood pressure
measurements taken during two or more contacts with a
health care provider.
Hypertension- definition
 Hypertension is defined by the Seventh Report of the
Joint National Committee on Prevention, Detection,
Evaluation, and Treatment of High Blood Pressure (JNC
7) as a systolic blood pressure greater than 140 mm Hg
and a diastolic pressure greater than 90 mm Hg based
on the average of two or more accurate blood pressure
measurements taken during two or more contacts with a
health care provider.
 World hypertension day: May 17
 The theme for World Hypertension Day 2013 is
“Healthy Heart Beat - Healthy Blood
Pressure”.
Global incidence
 As per the World Health Statistics 2012, of the estimated 57
million global deaths in 2008, 36 million (63%) were due to
noncommunicable diseases (NCDs). The largest proportion of
NCD deaths is caused by cardiovascular diseases (48%). In terms
of attributable deaths, raised blood pressure is one of the leading
behavioral and physiological risk factor to which 13% of global
deaths are attributed. Hypertension is reported to be the fourth
contributor to premature death in developed countries and the
seventh in developing countries.
National prevalence
 The prevalence of hypertension in the last six decades
has increased from 2% to 25% among urban residents
and from2% to 15% among the rural residents in
India. According to Directorate General of Health
Services, Ministry of Health and Family Welfare,
Government of India, the overall prevalence of
hypertension in India by 2020 will be159.46/1000
population
Classification

Blood pressure(mmhg)
Classsification Systolic Diastolic
Normal 119 or lower 79 or lower
Prehypertension 120-139 80-89
Stage1 hypertenson 140-159 90-99
Stage2 hypertension 160 0r higher 100 or higher
Causes
 In general the major causes of hypertension are the
following:
 Hectic and stress filled life style
 Unhealthy food habits
 Obesity
 Excessive consumption of liquors
 Smoking
 Over consumption of tea/coffee
 Insufficient rest and sleep
 Metabolic disorders
Contd……
 Hardening of the arteries
 Excessive use of pain killers and other strong
medicines
 Genetic disorders
 Over consumption of oily food and fast food
 High salt intake
 Emotional and Physical stress
 Family history of hypertension
Secondary causes
 Sleep apnoea
 Drug-induced or drug-related
 Chronic kidney disease
 Primary aldosteronism
 Renovascular disease
 Chronic steroid therapy and Cushing syndrome
 Phaeochromocytoma
 Acromegaly
 Thyroid or parathyroid disease
 Coarctation of the aorta
 Takayasu Arteritis

Primary hypertension
 Primary (essential) hypertension is the most common
form of hypertension, accounting for 90–95% of all
cases of hypertension. Insulin resistance, which is
common in obesity and is a component of syndrome X
(or the metabolic syndrome), is also thought to
contribute to hypertension
Risk factors for primary
hypertension
 Age: SBP increase progressively with increasing age. After 50, an
SBP>140 mmHg is a more important risk factor for CAD than
DBP.
 Alcohol:
 Cigarette smoking:increase the risk of CVD.
 Diabetes mellitus: hypertension is more common in diabetes
mellitus.
 Elevated serum lipids: primary risk factor for atherosclerosis.
 Excess dietary sodium:contribute to hypertension.
 Gender:Hypertension more prevalent in young adulthood.
After55yr,more prevalent in women.
 .
 Family history:
 Obesity
 Ethnicity: Twice as high in African Americans than that
of whites.
 Sedentary life style: Regular physical activity reduce
obesity and decrease BP.
 Socio economic status: more prevalent in people with
low socio economic status.
 Stress: Increase the incidence of hypertension
Secondary hypertension
 Secondary hypertension results from an identifiable
cause. Renal disease is the most common secondary
cause of hypertension. Hypertension can also be
caused by endocrine conditions, such as Cushing's
syndrome, hyperthyroidism, hypothyroidism,
acromegaly, Conn's syndrome or hyperaldosteronism,
hyperparathyroidism and pheochromocytoma.
Cause of Secondary
Hypertension
Diagnostic Tests Management
Renovascular disease Renal duplex ultrasonography, CT or MR
angiography, renal angiogram.
Balloon angioplasty in patients with FMD;
medical management with ACE inhibitor or
ARB in combination with a diuretic for
patients with atherosclerotic renal artery
disease.
Primary aldosteronism Plasma aldosterone renin ratio, salt loading
test for confirmation, CT scan of adrenal
and adrenal vein sampling for localization.
In a patient with adrenal hyperplasia or
bilateral functional adrenal adenoma, medical
therapy with aldosterone antagonist.
In a patient with unilateral functional
adenoma, adrenalectomy of the affected
adrenal gland.
Cushing syndrome Dexamethasone suppression test, salivary
cortisol levels, CT adrenal gland.
Treat primary cause for excess cortisol levels.
Pheochromocytoma Plasma metanephrines, 24-hour urinary
metanephrines and catecholamines, CT,
MRI, metaiodobenzylguanidine scan if CT or
MRI are not conclusive.
Adrenalectomy of the affected adrenal gland.
Coarctation of aorta Echocardiogram, MR angiography,
aortogram.
Angioplasty or surgical correction.
Renovascular disease Renal duplex ultrasonography, CT or MR
angiography, renal angiogram.
Balloon angioplasty in patient with FMD;
medical management with ACE inhibitor or
ARB in combination with a diuretic for patient
with atherosclerotic renal artery disease.
Essential hypertension or
idiopathic hypertension
 It is the most common form of hypertension, which
occurs in almost 90 percent of cases. The causes of
essential hyper tension is unknown, however, medical
studies and research have identified some factors
which cause hypertension. Some of these factors are
unhealthy dietary habits, tension, stress, insufficient
rest, smoking, excessive consumption of liquors,
obesity, metabolic disorders, excessive consumption of
tea and coffee etc
Hypertensive crisis
 Hypertensive crisis broadly covers both hypertensive
urgency and emergency. JNC 7 defines hypertensive
emergency as severe elevation in BP (>180/120
mmHg) complicated by evidence of impending or
progressive target organ dysfunction and
damage.When severe elevation in BP occurs without
acute target organ dysfunction or damage, it is defined
as hypertensive urgency
Hypertensive emergency
 previously "malignant hypertension", is diagnosed
when there is evidence of direct damage to one or
more organs as a result of the severely elevated blood
pressure. This may include hypertensive
encephalopathy, altered level of consciousness ,Retinal
papilloedema ,Chest pain ,myocardial infarction)
,aortic dissection, , signs of pulmonary
edema,deterioration of kidney function may occur.
Resistant hypertension
 Resistant hypertension is defined as hypertension that
remains above goal blood pressure in spite of
concurrent use of three antihypertensive agents
belonging to different antihypertensive drug classes
Hypertensive crisis
 Severely elevated blood pressure (equal to or greater
than a systolic 180 or diastolic of 110 — sometime
termed malignant or accelerated hypertension) is
referred to as a "hypertensive crisis.People with blood
pressures in this range may have no symptoms, but are
more likely to report headaches (22% of cases) and
dizziness than the general population.Other symptoms
accompanying a hypertensive crisis may include visual
deterioration or breathlessness due to heart failure or
a general feeling of malaise due to renal failure.
Pathophysiology
Etiological factors

sed periphral resistance

 sed venous compliance
sed venous return

cardiac preload

Diastolic dysfunction
Signs and symptoms.
 Headaches - Headaches may be experienced due to elevation in blood
pressure. Sometimes morning headaches can also be due to hypertension.
 Dizziness - Dizziness is often experience by people with high blood pressure.
However dizziness cannot always be treated as a symptom of hypertension. If
dizziness is experienced it is always wise to consult a medical practitioner.
 Heart pain
 Palpitations
 Nosebleeds - Nosebleeds without particular reason might be a symptom of
high blood pressure. It is better to check the blood pressure in such cases.
 Difficulty in breathing
 Tinnitus (ringing or buzzing in the ears)
 Blurred Vision
 Frequent urination
Diagnosis
 History and physical examination
 24-hour ambulatory blood pressure monitors and
home blood pressure monitoring
 Patterns of Blood Pressure
 Based on 24-hour ambulatory BP monitoring and
office BP readings, 4 patterns of BP have been
described
 sustained hypertension, Masked hypertension white
coat hypertension , normal dipping pattern
Home Blood Pressure Monitoring
 Home BP measurement guidelines recommend that a
validated device be used to measure BP at home Blood
pressure measurements using such validated devices
should be taken before an office visit, with at least 2
morning and 2 evening readings everyday for 1 week
(but discarding the readings of the first day), which
gives a total of 12 BP readings over a week, based on
which clinical decisions can be made. Hypertension is
defined as a mean home blood pressure of ≥135/85
mmHg. Home blood pressure monitoring provides an
inexpensive alternative to 24-hour ambulatory BP
monitoring.
 The recently released National Institute of Health and
Clinical Excellence (NICE) guidelines published in the
United Kingdom recommend that a diagnosis of
primary hypertension should be confirmed with 24-
hour ambulatory blood pressure monitoring or home
blood pressure monitoring rather than by relying
solely on office blood pressure measurement.
laboratoryTests
 Renal
 Microscopic urinalysis, proteinuria, BUN and/or
creatinine

 Endocrine
 Serum sodium, potassium, calcium, TSH

 Metabolic
 Fasting blood glucose, HDL, LDL, and total
cholesterol, triglycerides
Others
Electrocardiogram
Echo cardiography
On physical examination, hypertension may be
suspected on the basis of the presence of hypertensive
retinopathy detected by examination of the optic
fundus found in the back of the eye using
ophthalmoscopy
Prevention
 Maintain normal body weight for adults (e.g. body mass
index 20–25 kg/m2)
 Reduce dietary sodium intake to <100 mmol/ day (<6 g of
sodium chloride or <2.4 g of sodium per day)
 Engage in regular aerobic physical activity such as brisk
walking (≥30 min per day, most days of the week)
 Limit alcohol consumption to no more than 3 units/day in
men and no more than 2 units/day in women
 Consume a diet rich in fruit and vegetables (e.g. at least five
portions per day);
 Effective lifestyle modification may lower blood pressure
Management of Hypertension
Goals of Therapy
 The primary goal of therapy of hypertension should be
effective control of BP in order to prevent, reverse or
delay the progression of complications and thus reduce
the overall risk of an individual without adversely
affecting the quality of life. Patients should be
explained that the lifestyle modifications and drug
treatment is generally lifelong and regular drug
compliance is important
Initiation of therapy
 Having assessed the patient and determined the overall risk
profile, management of hypertension should proceed as
follows:
 In low risk patients, it is suggested to institute life style
modifications and observe BP for a period of 2-3 months,
before deciding whether to initiate drug therapy.
 In medium risk patients, institute life style modifications
and initiate drug therapy after 2-4 weeks, in case BP
remains above 140/90.
 In high and very high-risk groups, initiate immediate drug
treatment for hypertension and other risk factors in
addition to instituting life-style modification
Management
Me d i c a l M a n a g e m e n t
Lifestyle modifications
Medications
Modification Recommendation
Weight reduction Maintain normal body weight (body mass
index, 18.4–24.9 kg/m2)
Adopt DASH eating plan Consume diet rich in fruits, vegetables, low-
fat dairy products, with reduced content of
saturated and total fats
Dietary sodium reduction Reduce dietary sodium intake to no more
than 100 mmol/day (2.4g sodium or 6g
sodium chloride)
Physical activity Engage in regular aerobic physical activity
(e.g., brisk walking) at least 30 min/day,
most days of the week
Moderation of alcohol consumption Most men: limit consumption to no more
than two drinks/day‡
Most women and those who weigh less than
normal: no more than one drink/day
Adopt DASH (Dietary Approaches
to Stop Hypertension
 Eating more fruits, vegetables, and low-fat dairy foods
 Cutting back on foods that are high in saturated fat,
cholesterol, and trans fats
 Eating more whole grain products, fish, poultry, and
nuts
 Eating less red meat (especially processed meats) and
sweets
 Eating foods that are rich in magnesium, potassium,
and calcium
DASH diet
Food group No. of servings per day
Grains and grain products 7 or 8
vegetables 4 or 5
fruits 4or5
Low fat or fat free dairy products 2or 3
Meat, fish, poultry 2 or fewer
Nuts, seeds,and dry beans 4 or 5 weekly
 Different programs aimed to reduce psychological
stress such a biofeedback, relaxation or meditation are
advertised to reduce hypertension
Principles of drug treatment
 Over the past decade, the goals of treatment have gradually
shifted from optimal lowering of blood pressure, to patient’s
overall well being, control of associated risk factors and
protection from future target organ damage
 Achieve gradual reduction of blood pressure. Use low doses of
antihypertensive drugs to initiate therapy.
 Five classes of drugs can be recommended as first line treatment
for stage 1-2 hypertension1,2 These include :1) ACE inhibitors,
2) angiotensin II receptor blockers, 3) calcium channel blockers,
4) diuretics and 5) newer β-blockers.
 The Blood Pressure Lowering Treatment Trialists’ Collaboration
concluded that treatment with any commonly used regimen
reduces the risk of total major cardiovascular events and larger
reductions in blood pressure produce larger reductions in risk.
• Choice of an antihypertensive agent is influenced by age, concomitant
risk factors, presence of target organ damage, other co-existing
diseases,
• socioeconomic considerations, availability of the drug and past
experience of the physician.
• Combining low doses of two or more drugs having synergistic effect is
likely to produce lesser side effects. In 60-70 % of patients, goal blood
pressure will be achieved with two or more agents only. • Use of fixed
dose formulations should be considered to improve compliance.
• Drugs with synergistic effects should be combined pertinently to
enhance BP lowering effect so as to achieve target BP.
• Use of long acting drugs that provide 24-hour efficacy with once daily
administration ensures smooth and sustained control of blood
pressure; which in turn is expected to provide greater protection
against the risk of major cardiovascular events and target organ
damage. Once daily administration also improves patient compliance.
• Although antihypertensive therapy is generally lifelong, an effort to
decrease the dosage and number of antihypertensive drugs should be
considered after effective control of hypertension (step-down therapy).
• Due to a greater seasonal variation of temperatures in India, marginal
alterations in dosages of drugs may be needed from time to time.
Medications
 Several classes of medications, collectively referred to
as antihypertensive drugs, are currently available for
treating hypertension.. .One or more of these blood
pressure medicines are often used to treat high blood
pressure:
 Diuretics are also called water pills. They help your
kidneys remove some salt (sodium) from your body.
As a result, your blood vessels don't have to hold as
much fluid and your blood pressure goes down.
 Beta-blockers make the heart beat at a slower rate and with
less force.
 Angiotensin-converting enzyme inhibitors (also called ACE
inhibitors) relax your blood vessels, which lowers your blood
pressure.
 . Angiotensin II receptor blockers (also called ARBs)
work in about the same way as angiotensin-converting
enzyme inhibitors
.
 Calcium channel blockers relax blood vessels by stopping
calcium from entering cells.
Blood pressure medicines that are not used as often include:
 Alpha-blockers help relax your blood vessels, which
lowers your blood pressure.
 Centrally acting drugs signal your brain and nervous
system to relax your blood vessels.
 Vasodilators signal the muscles in the walls of blood
vessels to relax.
 Renin inhibitors, a newer type of medicine for treating
high blood pressure, act by relaxing your blood vessels
 Renin inhibitors work, as the name would suggest, by
inhibiting the activity of renin, the enzyme largely
responsible for angiotensin II levels. In clinical trials, renin
inhibitors have proven effective in not only lowering blood
pressure, but also keeping blood pressure levels steadier
throughout the day.One renin inhibitor, aliskiren
(Tekturna), was approved by the FDA in 2007. Other drugs
in this class are in development
 Two new techniques to treat resistant hypertension that are
undergoing clinical trials involve baroreceptor activation therapy and
renal artery denervation in order to lower blood pressure:
 Baroreceptor activation therapy is performed using a Rheos
baroreflex hypertension therapy system which is surgically implanted
in the subclavicular region. The electrodes connected to this device are
attached to the carotid body on each side of the neck. Activation of
baroreceptors leads to significant lowering of blood pressure.
The renal denervation system
 uses a catheter to perform radiofrequency ablation
when applied to the lumen of renal arteries through a
femoral access. In a study, 153 patients with resistant
hypertension (baseline BP of 176/98 + 17/15 mmHg)
underwent catheter-based renal sympathetic
denervation. Patients experienced a sustained BP
reduction averaging 32/14 mmHg at 24 months; 92%
had an office blood pressure reduction of >10mmHg
and 97% of patients were free of procedure-related
Complication
Conditions for which clinical trials demonstrate benefit
of specific classes of antihypertensive drugs.
 Heart Failure . In asymptomatic individuals with demonstrable
ventricular dysfunction, ACEIs and BBs are recommended. For
those with symptomatic ventricular dysfunction or end-stage
heart disease, ACEIs, BBs, ARBs and aldosterone blockers are
recommended along with loop diuretics.
 Diabetic Hypertension
 Combinations of two or more drugs are usually needed to
achieve the target goal of <130/80 mmHg. Thiazide diuretics,
BBs, ACEIs, ARBs, and CCBs are beneficial in reducing CVD and
stroke incidence in patients with diabetes. ACEI- or ARB-based
treatments favorably affect the progression of diabetic
nephropathy and reduce albuminuria, and ARBs have been
shown to reduce progression to macroalbuminuria.
 Chronic Kidney Disease: Hypertension appears in the
majority of these patients, and they should receive aggressive BP
management, often with three or more drugs to reach target BP
values of <130/80 mmHg. ACEIs and ARBs have demonstrated
favorable effects on the progression of diabetic and nondiabetic
renal disease.
 Cerebrovascular Disease
 The risks and benefits of acute lowering of BP during an acute
stroke are still unclear; control of BP at intermediate levels
(approximately 160/100 mmHg) is appropriate until the
condition has stabilized or improved. Recurrent stroke rates are
lowered by the combination of an ACEI and thiazide-type
diuretic.
Obesity and the metabolic syndrome
 Intensive lifestyle modification should be pursued in all
individuals with the metabolic syndrome, and appropriate
drug therapy should be instituted for each of its
components as indicated
 Left ventricular hypertrophy
Left ventricular hypertrophy (LVH) is an independent risk
factor that increases the risk of subsequent CVD. Regression
of LVH occurs with aggressive BP management, including
weight loss, sodium restriction, and treatment with all
classes of antihypertensive agents except the direct
vasodilators hydralazine, and minoxidil.
 Peripheral arterial disease
 Peripheral arterial disease (PAD) is equivalent in risk to
IHD. Any class of antihypertensive drugs can be used in
most PAD patients. Other risk factors should be managed
aggressively, and aspirin should be used.
 Hypertension in older persons
 Hypertension occurs in more than two-thirds of individuals
after age 65.This is also the population with the lowest
rates of BP control.Treatment recommendations for older
people with hypertension, including those who have
isolated systolic hypertension, should follow the same
principles outlined for the general care of hypertension
Hypertension in pregnancy
 Women with hypertension who become pregnant
should be followed carefully because of increased risks
to mother and fetus. Methyldopa, BBs, and
vasodilators are preferred medications for the safety
of the fetus.ACEI and ARBs should not be used during
pregnancy because of the potential for fetal defects and
should be avoided In some patients, preeclampsia may
develop into a hypertensive urgency or emergency and
may require hospitalization, intensive monitoring,
early fetal delivery, and parenteral antihypertensive
and anticonvulsant therapy
Agent Onset Duration Advantages Disadvantages
Nitroprusside Immediate 1-2 minutes Potent,
titratable
Cyanide,
isocyanide
Nitroglycerine 2-5 minutes 3-5 minutes Coronary
perfusion
Tolerance,
variable
efficacy
Fenoldopam <5 minutes 5-10 minutes Renal
perfusion
Increased
intraocular
pressure
Hydralazine 10-20 minutes 3-8 hours Eclampsia Tachycardia,
headache
Nicardipine 5-15 minutes 1-4 hours CNS protection Avoid in CHF
and cardiac
ischemia
Enalaprilat 15-30 minutes 6 hours CHF, acute LV
failure
Avoid in MI
Intravenous Agents for Hypertensive Emergencies
Complications of hypertension
 Hypertension is the most important preventable risk
factor for premature death.
 Ischemic heart disease
 Strokes
 Peripheral vascular disease,
 Other cardiovascular diseases
 , Including heart failure, aortic aneurysms, diffuse
atherosclerosis, and pulmonaryembolism
 Hypertension is also a risk factor for cognitive
impairment and dementia, and chronic kidney disease.
Other complications include hypertensive retinopathy
and hypertensive nephropathy.
 Bleeding from the aorta
 Target organ disease,POVD, nephrosclerosis
 Hypertensive encephalopathy
Nursing management
 Assessment
 History
 Past and present medical history
 Family history
 Risk factors
 symptoms
 Physical examination
 Checking vital signs
Nursing problems
 Decreased Cardiac Output related to increased
peripheral resistance and arterial stiffneff
 Acute Pain secondary to hypertension
 Activity Intolerance
 Imbalanced Nutrition : more than body
requirements
 Deficient Knowledge
 Ineffective therapeutic regimen
Researches
 Sesame and rice bran oil can treat high blood
pressure and cholesterol, study show Significant
blood pressure, cholesterol level reductions
Yoga benefits high blood pressure through promoting
relaxation of the mind and body. Practicing yoga helps
decrease the negative impacts of stress, including
tension, shallow breathing and elevated heart rate. It
also improves physical strength and flexibility, plus
may assist with weight loss
Nursing Management of Hypertension

More Related Content

What's hot (20)

HYPERTENSION
HYPERTENSIONHYPERTENSION
HYPERTENSION
 
Anuerysm
AnuerysmAnuerysm
Anuerysm
 
Congestive cardiac failure
Congestive cardiac failureCongestive cardiac failure
Congestive cardiac failure
 
Atherosclerosis
AtherosclerosisAtherosclerosis
Atherosclerosis
 
Hypertension
HypertensionHypertension
Hypertension
 
Coronary heart diseases ppt
Coronary heart diseases pptCoronary heart diseases ppt
Coronary heart diseases ppt
 
Cardiogenic shock
Cardiogenic shockCardiogenic shock
Cardiogenic shock
 
Angina pectoris
Angina pectorisAngina pectoris
Angina pectoris
 
Ischemic Heart Disease.ppt
Ischemic Heart Disease.pptIschemic Heart Disease.ppt
Ischemic Heart Disease.ppt
 
Hypotension
HypotensionHypotension
Hypotension
 
Hypotension
HypotensionHypotension
Hypotension
 
Myocardial infarction
Myocardial infarctionMyocardial infarction
Myocardial infarction
 
Coronary Artery Disease
Coronary Artery DiseaseCoronary Artery Disease
Coronary Artery Disease
 
hypotension ppt.pptx
hypotension ppt.pptxhypotension ppt.pptx
hypotension ppt.pptx
 
Chronic renal failure
Chronic renal failureChronic renal failure
Chronic renal failure
 
Endocarditis
EndocarditisEndocarditis
Endocarditis
 
Hypo thyroidism
Hypo thyroidismHypo thyroidism
Hypo thyroidism
 
Pleural effusion
Pleural effusionPleural effusion
Pleural effusion
 
MYOCARDIAL INFARCTION
MYOCARDIAL INFARCTIONMYOCARDIAL INFARCTION
MYOCARDIAL INFARCTION
 
Diabetes insipidus
Diabetes insipidusDiabetes insipidus
Diabetes insipidus
 

Viewers also liked

hypertension, CCF
hypertension, CCFhypertension, CCF
hypertension, CCFligi xavier
 
Hypertension power point
Hypertension power pointHypertension power point
Hypertension power pointkreid204
 
Hypertension - Nursing Practise
Hypertension - Nursing PractiseHypertension - Nursing Practise
Hypertension - Nursing PractiseMónica Roque
 
Dental Management of patient with Hypertension
Dental Management of patient with HypertensionDental Management of patient with Hypertension
Dental Management of patient with HypertensionIraqi Dental Academy
 
Pathophysiology hypertension.
Pathophysiology hypertension.Pathophysiology hypertension.
Pathophysiology hypertension.Shaikhani.
 
hypotension and hypertention emergencies in the dental office
hypotension and hypertention emergencies in the dental officehypotension and hypertention emergencies in the dental office
hypotension and hypertention emergencies in the dental officevahid199212
 
HYPERTENSION & ITS MANAGEMENT IN DENTISTRY
HYPERTENSION & ITS MANAGEMENT IN DENTISTRYHYPERTENSION & ITS MANAGEMENT IN DENTISTRY
HYPERTENSION & ITS MANAGEMENT IN DENTISTRYAshok Kumar
 
Hypertension 2013 Pathophysiology
Hypertension 2013 PathophysiologyHypertension 2013 Pathophysiology
Hypertension 2013 PathophysiologyGunter Hennersdorf
 
Nursing Care of Clients with Hypertension
Nursing Care of Clients with HypertensionNursing Care of Clients with Hypertension
Nursing Care of Clients with HypertensionCarmela Domocmat
 
What is hypertension?
What is hypertension?What is hypertension?
What is hypertension?honhungoc
 
تمارين لشد الجسم
تمارين لشد الجسمتمارين لشد الجسم
تمارين لشد الجسمrelationsmiddle
 
Role of Primary Heath Care Nurse in caring Hypertensive patient & family
Role of Primary Heath Care  Nurse in  caring Hypertensive patient & family Role of Primary Heath Care  Nurse in  caring Hypertensive patient & family
Role of Primary Heath Care Nurse in caring Hypertensive patient & family Shanta Peter
 
Htn crisis
Htn crisis Htn crisis
Htn crisis whale902
 
Arterial hypertension
Arterial hypertensionArterial hypertension
Arterial hypertensionnizhgma.ru
 
Jr approach to the patient with varicose veins april 2010
Jr approach to the patient with varicose veins april 2010Jr approach to the patient with varicose veins april 2010
Jr approach to the patient with varicose veins april 2010John Rowen
 

Viewers also liked (20)

hypertension, CCF
hypertension, CCFhypertension, CCF
hypertension, CCF
 
Hypertension power point
Hypertension power pointHypertension power point
Hypertension power point
 
Ekaaa
EkaaaEkaaa
Ekaaa
 
Hypertension - Nursing Practise
Hypertension - Nursing PractiseHypertension - Nursing Practise
Hypertension - Nursing Practise
 
Hypertension Patient Self Monitoring
Hypertension Patient Self MonitoringHypertension Patient Self Monitoring
Hypertension Patient Self Monitoring
 
Dental Management of patient with Hypertension
Dental Management of patient with HypertensionDental Management of patient with Hypertension
Dental Management of patient with Hypertension
 
Pathophysiology hypertension.
Pathophysiology hypertension.Pathophysiology hypertension.
Pathophysiology hypertension.
 
hypotension and hypertention emergencies in the dental office
hypotension and hypertention emergencies in the dental officehypotension and hypertention emergencies in the dental office
hypotension and hypertention emergencies in the dental office
 
HYPERTENSION & ITS MANAGEMENT IN DENTISTRY
HYPERTENSION & ITS MANAGEMENT IN DENTISTRYHYPERTENSION & ITS MANAGEMENT IN DENTISTRY
HYPERTENSION & ITS MANAGEMENT IN DENTISTRY
 
Hypertension 2013 Pathophysiology
Hypertension 2013 PathophysiologyHypertension 2013 Pathophysiology
Hypertension 2013 Pathophysiology
 
Hypertension
HypertensionHypertension
Hypertension
 
Nursing Care of Clients with Hypertension
Nursing Care of Clients with HypertensionNursing Care of Clients with Hypertension
Nursing Care of Clients with Hypertension
 
What is hypertension?
What is hypertension?What is hypertension?
What is hypertension?
 
تمارين لشد الجسم
تمارين لشد الجسمتمارين لشد الجسم
تمارين لشد الجسم
 
Role of Primary Heath Care Nurse in caring Hypertensive patient & family
Role of Primary Heath Care  Nurse in  caring Hypertensive patient & family Role of Primary Heath Care  Nurse in  caring Hypertensive patient & family
Role of Primary Heath Care Nurse in caring Hypertensive patient & family
 
Htn crisis
Htn crisis Htn crisis
Htn crisis
 
Arterial hypertension
Arterial hypertensionArterial hypertension
Arterial hypertension
 
Jr approach to the patient with varicose veins april 2010
Jr approach to the patient with varicose veins april 2010Jr approach to the patient with varicose veins april 2010
Jr approach to the patient with varicose veins april 2010
 
Typhoid disease
Typhoid diseaseTyphoid disease
Typhoid disease
 
Eclampsia
EclampsiaEclampsia
Eclampsia
 

Similar to Nursing Management of Hypertension

Accerlerated hypertension
Accerlerated hypertensionAccerlerated hypertension
Accerlerated hypertensionSachin Verma
 
HYPERTENSION TOPIC OF SEMINAR FOR NURSING STUDENTS.pptx
HYPERTENSION TOPIC OF SEMINAR  FOR NURSING STUDENTS.pptxHYPERTENSION TOPIC OF SEMINAR  FOR NURSING STUDENTS.pptx
HYPERTENSION TOPIC OF SEMINAR FOR NURSING STUDENTS.pptxApurva Dwivedi
 
Unit 1_Understanding HTN(1).pptx
Unit 1_Understanding HTN(1).pptxUnit 1_Understanding HTN(1).pptx
Unit 1_Understanding HTN(1).pptxImanuIliyas
 
CONTROLLING HYPERTENSION: A BRIEF REVIEW
CONTROLLING HYPERTENSION: A BRIEF REVIEWCONTROLLING HYPERTENSION: A BRIEF REVIEW
CONTROLLING HYPERTENSION: A BRIEF REVIEWVignan University
 
1. Hypertension (2).pptx
1. Hypertension (2).pptx1. Hypertension (2).pptx
1. Hypertension (2).pptxsamsonkiflu
 
PATHOLOGY OF HYPERTENSION .ppt
PATHOLOGY OF HYPERTENSION           .pptPATHOLOGY OF HYPERTENSION           .ppt
PATHOLOGY OF HYPERTENSION .pptImtiyaz60
 
hypertension-definition,causes,diagnosis.pptx
hypertension-definition,causes,diagnosis.pptxhypertension-definition,causes,diagnosis.pptx
hypertension-definition,causes,diagnosis.pptxWILLIAM485410
 
Hypertention presentation by dhanya v thilakam
Hypertention presentation by dhanya v thilakamHypertention presentation by dhanya v thilakam
Hypertention presentation by dhanya v thilakamThilakam Dhanya
 
1 hypertension
1 hypertension1 hypertension
1 hypertensiondoctorkais
 
Hypertension - Nutrition In Disease
Hypertension - Nutrition In DiseaseHypertension - Nutrition In Disease
Hypertension - Nutrition In DiseaseRANJANI GUNASEKARAN
 
Systemic Hypertension
Systemic HypertensionSystemic Hypertension
Systemic HypertensionJawid786
 

Similar to Nursing Management of Hypertension (20)

Accerlerated hypertension
Accerlerated hypertensionAccerlerated hypertension
Accerlerated hypertension
 
Hypertension
HypertensionHypertension
Hypertension
 
hypertension.docx
hypertension.docxhypertension.docx
hypertension.docx
 
85188976 case-study
85188976 case-study85188976 case-study
85188976 case-study
 
Systemic hypertension
Systemic hypertensionSystemic hypertension
Systemic hypertension
 
HYPERTENSION TOPIC OF SEMINAR FOR NURSING STUDENTS.pptx
HYPERTENSION TOPIC OF SEMINAR  FOR NURSING STUDENTS.pptxHYPERTENSION TOPIC OF SEMINAR  FOR NURSING STUDENTS.pptx
HYPERTENSION TOPIC OF SEMINAR FOR NURSING STUDENTS.pptx
 
Hypertension
HypertensionHypertension
Hypertension
 
Unit 1_Understanding HTN(1).pptx
Unit 1_Understanding HTN(1).pptxUnit 1_Understanding HTN(1).pptx
Unit 1_Understanding HTN(1).pptx
 
Hypertension
HypertensionHypertension
Hypertension
 
CONTROLLING HYPERTENSION: A BRIEF REVIEW
CONTROLLING HYPERTENSION: A BRIEF REVIEWCONTROLLING HYPERTENSION: A BRIEF REVIEW
CONTROLLING HYPERTENSION: A BRIEF REVIEW
 
1. Hypertension (2).pptx
1. Hypertension (2).pptx1. Hypertension (2).pptx
1. Hypertension (2).pptx
 
PATHOLOGY OF HYPERTENSION .ppt
PATHOLOGY OF HYPERTENSION           .pptPATHOLOGY OF HYPERTENSION           .ppt
PATHOLOGY OF HYPERTENSION .ppt
 
hypertension-definition,causes,diagnosis.pptx
hypertension-definition,causes,diagnosis.pptxhypertension-definition,causes,diagnosis.pptx
hypertension-definition,causes,diagnosis.pptx
 
Hypertention presentation by dhanya v thilakam
Hypertention presentation by dhanya v thilakamHypertention presentation by dhanya v thilakam
Hypertention presentation by dhanya v thilakam
 
10 hypertension
10 hypertension10 hypertension
10 hypertension
 
1 hypertension
1 hypertension1 hypertension
1 hypertension
 
Hypertensi Emergency-1.ppt
Hypertensi Emergency-1.pptHypertensi Emergency-1.ppt
Hypertensi Emergency-1.ppt
 
Hypertension
HypertensionHypertension
Hypertension
 
Hypertension - Nutrition In Disease
Hypertension - Nutrition In DiseaseHypertension - Nutrition In Disease
Hypertension - Nutrition In Disease
 
Systemic Hypertension
Systemic HypertensionSystemic Hypertension
Systemic Hypertension
 

More from ligi xavier

Seminar on anatomy and physiology of git
Seminar on anatomy and physiology of gitSeminar on anatomy and physiology of git
Seminar on anatomy and physiology of gitligi xavier
 
Staffing,estmn,scheduling
Staffing,estmn,schedulingStaffing,estmn,scheduling
Staffing,estmn,schedulingligi xavier
 
Professional oranisations
Professional oranisationsProfessional oranisations
Professional oranisationsligi xavier
 
Ppt 0 n cns, spinal cord
Ppt  0 n cns, spinal cordPpt  0 n cns, spinal cord
Ppt 0 n cns, spinal cordligi xavier
 
Anatomy and physiology of heart, lung ,
Anatomy and physiology of heart, lung ,Anatomy and physiology of heart, lung ,
Anatomy and physiology of heart, lung ,ligi xavier
 
Physiology of lung
Physiology of lungPhysiology of lung
Physiology of lungligi xavier
 
Seminar on nephritis, nephrotic syndrome,bladder cancer
Seminar on nephritis, nephrotic syndrome,bladder cancerSeminar on nephritis, nephrotic syndrome,bladder cancer
Seminar on nephritis, nephrotic syndrome,bladder cancerligi xavier
 

More from ligi xavier (11)

PPT 0n CNS
PPT  0n CNSPPT  0n CNS
PPT 0n CNS
 
Seminar on anatomy and physiology of git
Seminar on anatomy and physiology of gitSeminar on anatomy and physiology of git
Seminar on anatomy and physiology of git
 
Staffing,estmn,scheduling
Staffing,estmn,schedulingStaffing,estmn,scheduling
Staffing,estmn,scheduling
 
Sdl,cai, pi
Sdl,cai, piSdl,cai, pi
Sdl,cai, pi
 
Professional oranisations
Professional oranisationsProfessional oranisations
Professional oranisations
 
ear disorders
ear disordersear disorders
ear disorders
 
Ppt 0 n cns, spinal cord
Ppt  0 n cns, spinal cordPpt  0 n cns, spinal cord
Ppt 0 n cns, spinal cord
 
Anatomy and physiology of heart, lung ,
Anatomy and physiology of heart, lung ,Anatomy and physiology of heart, lung ,
Anatomy and physiology of heart, lung ,
 
Physiology of lung
Physiology of lungPhysiology of lung
Physiology of lung
 
Icsol
IcsolIcsol
Icsol
 
Seminar on nephritis, nephrotic syndrome,bladder cancer
Seminar on nephritis, nephrotic syndrome,bladder cancerSeminar on nephritis, nephrotic syndrome,bladder cancer
Seminar on nephritis, nephrotic syndrome,bladder cancer
 

Recently uploaded

GLYCOSIDES Classification Of GLYCOSIDES Chemical Tests Glycosides
GLYCOSIDES Classification Of GLYCOSIDES  Chemical Tests GlycosidesGLYCOSIDES Classification Of GLYCOSIDES  Chemical Tests Glycosides
GLYCOSIDES Classification Of GLYCOSIDES Chemical Tests GlycosidesNandakishor Bhaurao Deshmukh
 
projectile motion, impulse and moment
projectile  motion, impulse  and  momentprojectile  motion, impulse  and  moment
projectile motion, impulse and momentdonamiaquintan2
 
How we decide powerpoint presentation.pptx
How we decide powerpoint presentation.pptxHow we decide powerpoint presentation.pptx
How we decide powerpoint presentation.pptxJosielynTars
 
Abnormal LFTs rate of deco and NAFLD.pptx
Abnormal LFTs rate of deco and NAFLD.pptxAbnormal LFTs rate of deco and NAFLD.pptx
Abnormal LFTs rate of deco and NAFLD.pptxzeus70441
 
linear Regression, multiple Regression and Annova
linear Regression, multiple Regression and Annovalinear Regression, multiple Regression and Annova
linear Regression, multiple Regression and AnnovaMansi Rastogi
 
GenAI talk for Young at Wageningen University & Research (WUR) March 2024
GenAI talk for Young at Wageningen University & Research (WUR) March 2024GenAI talk for Young at Wageningen University & Research (WUR) March 2024
GenAI talk for Young at Wageningen University & Research (WUR) March 2024Jene van der Heide
 
well logging & petrophysical analysis.pptx
well logging & petrophysical analysis.pptxwell logging & petrophysical analysis.pptx
well logging & petrophysical analysis.pptxzaydmeerab121
 
Combining Asynchronous Task Parallelism and Intel SGX for Secure Deep Learning
Combining Asynchronous Task Parallelism and Intel SGX for Secure Deep LearningCombining Asynchronous Task Parallelism and Intel SGX for Secure Deep Learning
Combining Asynchronous Task Parallelism and Intel SGX for Secure Deep Learningvschiavoni
 
办理麦克马斯特大学毕业证成绩单|购买加拿大文凭证书
办理麦克马斯特大学毕业证成绩单|购买加拿大文凭证书办理麦克马斯特大学毕业证成绩单|购买加拿大文凭证书
办理麦克马斯特大学毕业证成绩单|购买加拿大文凭证书zdzoqco
 
final waves properties grade 7 - third quarter
final waves properties grade 7 - third quarterfinal waves properties grade 7 - third quarter
final waves properties grade 7 - third quarterHanHyoKim
 
DOG BITE management in pediatrics # for Pediatric pgs# topic presentation # f...
DOG BITE management in pediatrics # for Pediatric pgs# topic presentation # f...DOG BITE management in pediatrics # for Pediatric pgs# topic presentation # f...
DOG BITE management in pediatrics # for Pediatric pgs# topic presentation # f...HafsaHussainp
 
Charateristics of the Angara-A5 spacecraft launched from the Vostochny Cosmod...
Charateristics of the Angara-A5 spacecraft launched from the Vostochny Cosmod...Charateristics of the Angara-A5 spacecraft launched from the Vostochny Cosmod...
Charateristics of the Angara-A5 spacecraft launched from the Vostochny Cosmod...Christina Parmionova
 
complex analysis best book for solving questions.pdf
complex analysis best book for solving questions.pdfcomplex analysis best book for solving questions.pdf
complex analysis best book for solving questions.pdfSubhamKumar3239
 
whole genome sequencing new and its types including shortgun and clone by clone
whole genome sequencing new  and its types including shortgun and clone by clonewhole genome sequencing new  and its types including shortgun and clone by clone
whole genome sequencing new and its types including shortgun and clone by clonechaudhary charan shingh university
 
Explainable AI for distinguishing future climate change scenarios
Explainable AI for distinguishing future climate change scenariosExplainable AI for distinguishing future climate change scenarios
Explainable AI for distinguishing future climate change scenariosZachary Labe
 
Science (Communication) and Wikipedia - Potentials and Pitfalls
Science (Communication) and Wikipedia - Potentials and PitfallsScience (Communication) and Wikipedia - Potentials and Pitfalls
Science (Communication) and Wikipedia - Potentials and PitfallsDobusch Leonhard
 
6.1 Pests of Groundnut_Binomics_Identification_Dr.UPR
6.1 Pests of Groundnut_Binomics_Identification_Dr.UPR6.1 Pests of Groundnut_Binomics_Identification_Dr.UPR
6.1 Pests of Groundnut_Binomics_Identification_Dr.UPRPirithiRaju
 

Recently uploaded (20)

GLYCOSIDES Classification Of GLYCOSIDES Chemical Tests Glycosides
GLYCOSIDES Classification Of GLYCOSIDES  Chemical Tests GlycosidesGLYCOSIDES Classification Of GLYCOSIDES  Chemical Tests Glycosides
GLYCOSIDES Classification Of GLYCOSIDES Chemical Tests Glycosides
 
projectile motion, impulse and moment
projectile  motion, impulse  and  momentprojectile  motion, impulse  and  moment
projectile motion, impulse and moment
 
How we decide powerpoint presentation.pptx
How we decide powerpoint presentation.pptxHow we decide powerpoint presentation.pptx
How we decide powerpoint presentation.pptx
 
Interferons.pptx.
Interferons.pptx.Interferons.pptx.
Interferons.pptx.
 
Abnormal LFTs rate of deco and NAFLD.pptx
Abnormal LFTs rate of deco and NAFLD.pptxAbnormal LFTs rate of deco and NAFLD.pptx
Abnormal LFTs rate of deco and NAFLD.pptx
 
AZOTOBACTER AS BIOFERILIZER.PPTX
AZOTOBACTER AS BIOFERILIZER.PPTXAZOTOBACTER AS BIOFERILIZER.PPTX
AZOTOBACTER AS BIOFERILIZER.PPTX
 
linear Regression, multiple Regression and Annova
linear Regression, multiple Regression and Annovalinear Regression, multiple Regression and Annova
linear Regression, multiple Regression and Annova
 
GenAI talk for Young at Wageningen University & Research (WUR) March 2024
GenAI talk for Young at Wageningen University & Research (WUR) March 2024GenAI talk for Young at Wageningen University & Research (WUR) March 2024
GenAI talk for Young at Wageningen University & Research (WUR) March 2024
 
well logging & petrophysical analysis.pptx
well logging & petrophysical analysis.pptxwell logging & petrophysical analysis.pptx
well logging & petrophysical analysis.pptx
 
Combining Asynchronous Task Parallelism and Intel SGX for Secure Deep Learning
Combining Asynchronous Task Parallelism and Intel SGX for Secure Deep LearningCombining Asynchronous Task Parallelism and Intel SGX for Secure Deep Learning
Combining Asynchronous Task Parallelism and Intel SGX for Secure Deep Learning
 
办理麦克马斯特大学毕业证成绩单|购买加拿大文凭证书
办理麦克马斯特大学毕业证成绩单|购买加拿大文凭证书办理麦克马斯特大学毕业证成绩单|购买加拿大文凭证书
办理麦克马斯特大学毕业证成绩单|购买加拿大文凭证书
 
final waves properties grade 7 - third quarter
final waves properties grade 7 - third quarterfinal waves properties grade 7 - third quarter
final waves properties grade 7 - third quarter
 
PLASMODIUM. PPTX
PLASMODIUM. PPTXPLASMODIUM. PPTX
PLASMODIUM. PPTX
 
DOG BITE management in pediatrics # for Pediatric pgs# topic presentation # f...
DOG BITE management in pediatrics # for Pediatric pgs# topic presentation # f...DOG BITE management in pediatrics # for Pediatric pgs# topic presentation # f...
DOG BITE management in pediatrics # for Pediatric pgs# topic presentation # f...
 
Charateristics of the Angara-A5 spacecraft launched from the Vostochny Cosmod...
Charateristics of the Angara-A5 spacecraft launched from the Vostochny Cosmod...Charateristics of the Angara-A5 spacecraft launched from the Vostochny Cosmod...
Charateristics of the Angara-A5 spacecraft launched from the Vostochny Cosmod...
 
complex analysis best book for solving questions.pdf
complex analysis best book for solving questions.pdfcomplex analysis best book for solving questions.pdf
complex analysis best book for solving questions.pdf
 
whole genome sequencing new and its types including shortgun and clone by clone
whole genome sequencing new  and its types including shortgun and clone by clonewhole genome sequencing new  and its types including shortgun and clone by clone
whole genome sequencing new and its types including shortgun and clone by clone
 
Explainable AI for distinguishing future climate change scenarios
Explainable AI for distinguishing future climate change scenariosExplainable AI for distinguishing future climate change scenarios
Explainable AI for distinguishing future climate change scenarios
 
Science (Communication) and Wikipedia - Potentials and Pitfalls
Science (Communication) and Wikipedia - Potentials and PitfallsScience (Communication) and Wikipedia - Potentials and Pitfalls
Science (Communication) and Wikipedia - Potentials and Pitfalls
 
6.1 Pests of Groundnut_Binomics_Identification_Dr.UPR
6.1 Pests of Groundnut_Binomics_Identification_Dr.UPR6.1 Pests of Groundnut_Binomics_Identification_Dr.UPR
6.1 Pests of Groundnut_Binomics_Identification_Dr.UPR
 

Nursing Management of Hypertension

  • 2. Blood pressure  In normal circulation, pressure is exerted by the flow of blood through the heart and blood vessels. It is the product of cardiac output multiplied by peripheral resistance. Normal blood pressure at rest is within the range of 100-140mmHg systolic (top reading) and 60- 90mmHg diastolic .
  • 3. Determinants of BP and regulation  These are the fundamental factors which determine the value of BP. They are  1. Cardiac output  2.peripheral vascular resistance These are also called as factors controlling BP.  BP= cardiac output X PVR
  • 4. Regulatory mechanisms  Short term: Short term regulations are achieved by neural regulations where as long term regulations are achieved by controlling blood volume and Na retension via renal mechanisms.  Nervous System Control :BP by changing blood distribution in the body and by changing blood vessel diameter. Sympathetic & Parasympathetic activity will affects veins, arteries & heart to control HR and force of contraction
  • 5.  Baroreceptors :Baroreceptors are stretch receptors found in the carotid body, aortic body and the wall of all large arteries of the neck and thorax. Baroreceptors entered the medululla Secondary signals inhibit the vasoconstrictor center of medulla and excite the vagal parasympathetic center effect vasodilatation of the veins and arterioles decreased heart rate and strength of heart contractiont herefore, causes arterial pressure to decrease (as decrease in PR and CO) Conversely, low pressure has opposite effects,reflexly causing the pressure rise back to normal
  • 6.  Increased Parasympathetic Activity: Effect of increased parasympathetic and decreased sympathetic activity on heart and blood pressure: Increased activity of vagus (parasympathetic) nerve .  Decreased activity of sympathetic cardiac Nerves Reduction of heart rate .Lower cardiac output .Lower blood pressure
  • 7. Long term  long term control is achieved by adjusting the blood volume and lowering Ca concentration in the VSM.  Hormones :1)ADH reduces water excreation and causes water conservation.2) Renin ultimately cause production of angiotensin II causes aldosterone production which leads to the water and sodium retension.  ANP:released when atria are stretched . it causes dieresis and reduce blood volume and BP.  .
  • 8.  Role of Ca ions in the VSM : Its accumulation causes rise in the vascular tone and increases the vascular tone  Endocrine system: stimulation of SNS results in release of epinephrine along with small fraction of nor epinephrine by adrenal medulla. epinephrine increases CO by increasing HR and myocardial contractility
  • 9. Factors affecting BP  A. PHYSIOLOGICAL  Age :tends to increase in elder people.  Sex:before the onset of menopause women have little lower BP than that of males of same age group.after menopause women have little higher BP than that of males.  Meals: after meals BP is higher.  Emotion: range and panic may rise BP.  Exposure to cold : increase BP.inorder to preserve body heat,body tries to keep temperature by Cutaneous vaso constriction as a result of SNS stimulation.  Excercise  Sleep:cause fall of BP.  Circardian rhythm: BPis highest in the morning and least in the night.
  • 10.  B. PATHOLOGICAL  Clinical conditions alter BP include renal artery senosis, pheochromacytoma and pre eclampsia  Drug induced: sympathetic stimulants like adrenalin,nor adrenalin, andphenylephrine rise BP, while vascular smooth muscle relaxants like hydralazine reduces BP.
  • 11. Hypertension- definition  Hypertension is defined by the Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7) as a systolic blood pressure greater than 140 mm Hg and a diastolic pressure greater than 90 mm Hg based on the average of two or more accurate blood pressure measurements taken during two or more contacts with a health care provider.
  • 12. Hypertension- definition  Hypertension is defined by the Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7) as a systolic blood pressure greater than 140 mm Hg and a diastolic pressure greater than 90 mm Hg based on the average of two or more accurate blood pressure measurements taken during two or more contacts with a health care provider.
  • 13.  World hypertension day: May 17  The theme for World Hypertension Day 2013 is “Healthy Heart Beat - Healthy Blood Pressure”.
  • 14. Global incidence  As per the World Health Statistics 2012, of the estimated 57 million global deaths in 2008, 36 million (63%) were due to noncommunicable diseases (NCDs). The largest proportion of NCD deaths is caused by cardiovascular diseases (48%). In terms of attributable deaths, raised blood pressure is one of the leading behavioral and physiological risk factor to which 13% of global deaths are attributed. Hypertension is reported to be the fourth contributor to premature death in developed countries and the seventh in developing countries.
  • 15. National prevalence  The prevalence of hypertension in the last six decades has increased from 2% to 25% among urban residents and from2% to 15% among the rural residents in India. According to Directorate General of Health Services, Ministry of Health and Family Welfare, Government of India, the overall prevalence of hypertension in India by 2020 will be159.46/1000 population
  • 16. Classification  Blood pressure(mmhg) Classsification Systolic Diastolic Normal 119 or lower 79 or lower Prehypertension 120-139 80-89 Stage1 hypertenson 140-159 90-99 Stage2 hypertension 160 0r higher 100 or higher
  • 17. Causes  In general the major causes of hypertension are the following:  Hectic and stress filled life style  Unhealthy food habits  Obesity  Excessive consumption of liquors  Smoking  Over consumption of tea/coffee  Insufficient rest and sleep  Metabolic disorders
  • 18. Contd……  Hardening of the arteries  Excessive use of pain killers and other strong medicines  Genetic disorders  Over consumption of oily food and fast food  High salt intake  Emotional and Physical stress  Family history of hypertension
  • 19. Secondary causes  Sleep apnoea  Drug-induced or drug-related  Chronic kidney disease  Primary aldosteronism  Renovascular disease  Chronic steroid therapy and Cushing syndrome  Phaeochromocytoma  Acromegaly  Thyroid or parathyroid disease  Coarctation of the aorta  Takayasu Arteritis 
  • 20. Primary hypertension  Primary (essential) hypertension is the most common form of hypertension, accounting for 90–95% of all cases of hypertension. Insulin resistance, which is common in obesity and is a component of syndrome X (or the metabolic syndrome), is also thought to contribute to hypertension
  • 21. Risk factors for primary hypertension  Age: SBP increase progressively with increasing age. After 50, an SBP>140 mmHg is a more important risk factor for CAD than DBP.  Alcohol:  Cigarette smoking:increase the risk of CVD.  Diabetes mellitus: hypertension is more common in diabetes mellitus.  Elevated serum lipids: primary risk factor for atherosclerosis.  Excess dietary sodium:contribute to hypertension.  Gender:Hypertension more prevalent in young adulthood. After55yr,more prevalent in women.  .
  • 22.  Family history:  Obesity  Ethnicity: Twice as high in African Americans than that of whites.  Sedentary life style: Regular physical activity reduce obesity and decrease BP.  Socio economic status: more prevalent in people with low socio economic status.  Stress: Increase the incidence of hypertension
  • 23. Secondary hypertension  Secondary hypertension results from an identifiable cause. Renal disease is the most common secondary cause of hypertension. Hypertension can also be caused by endocrine conditions, such as Cushing's syndrome, hyperthyroidism, hypothyroidism, acromegaly, Conn's syndrome or hyperaldosteronism, hyperparathyroidism and pheochromocytoma.
  • 24. Cause of Secondary Hypertension Diagnostic Tests Management Renovascular disease Renal duplex ultrasonography, CT or MR angiography, renal angiogram. Balloon angioplasty in patients with FMD; medical management with ACE inhibitor or ARB in combination with a diuretic for patients with atherosclerotic renal artery disease. Primary aldosteronism Plasma aldosterone renin ratio, salt loading test for confirmation, CT scan of adrenal and adrenal vein sampling for localization. In a patient with adrenal hyperplasia or bilateral functional adrenal adenoma, medical therapy with aldosterone antagonist. In a patient with unilateral functional adenoma, adrenalectomy of the affected adrenal gland. Cushing syndrome Dexamethasone suppression test, salivary cortisol levels, CT adrenal gland. Treat primary cause for excess cortisol levels. Pheochromocytoma Plasma metanephrines, 24-hour urinary metanephrines and catecholamines, CT, MRI, metaiodobenzylguanidine scan if CT or MRI are not conclusive. Adrenalectomy of the affected adrenal gland. Coarctation of aorta Echocardiogram, MR angiography, aortogram. Angioplasty or surgical correction. Renovascular disease Renal duplex ultrasonography, CT or MR angiography, renal angiogram. Balloon angioplasty in patient with FMD; medical management with ACE inhibitor or ARB in combination with a diuretic for patient with atherosclerotic renal artery disease.
  • 25. Essential hypertension or idiopathic hypertension  It is the most common form of hypertension, which occurs in almost 90 percent of cases. The causes of essential hyper tension is unknown, however, medical studies and research have identified some factors which cause hypertension. Some of these factors are unhealthy dietary habits, tension, stress, insufficient rest, smoking, excessive consumption of liquors, obesity, metabolic disorders, excessive consumption of tea and coffee etc
  • 26. Hypertensive crisis  Hypertensive crisis broadly covers both hypertensive urgency and emergency. JNC 7 defines hypertensive emergency as severe elevation in BP (>180/120 mmHg) complicated by evidence of impending or progressive target organ dysfunction and damage.When severe elevation in BP occurs without acute target organ dysfunction or damage, it is defined as hypertensive urgency
  • 27. Hypertensive emergency  previously "malignant hypertension", is diagnosed when there is evidence of direct damage to one or more organs as a result of the severely elevated blood pressure. This may include hypertensive encephalopathy, altered level of consciousness ,Retinal papilloedema ,Chest pain ,myocardial infarction) ,aortic dissection, , signs of pulmonary edema,deterioration of kidney function may occur.
  • 28. Resistant hypertension  Resistant hypertension is defined as hypertension that remains above goal blood pressure in spite of concurrent use of three antihypertensive agents belonging to different antihypertensive drug classes
  • 29. Hypertensive crisis  Severely elevated blood pressure (equal to or greater than a systolic 180 or diastolic of 110 — sometime termed malignant or accelerated hypertension) is referred to as a "hypertensive crisis.People with blood pressures in this range may have no symptoms, but are more likely to report headaches (22% of cases) and dizziness than the general population.Other symptoms accompanying a hypertensive crisis may include visual deterioration or breathlessness due to heart failure or a general feeling of malaise due to renal failure.
  • 30. Pathophysiology Etiological factors  sed periphral resistance   sed venous compliance sed venous return  cardiac preload  Diastolic dysfunction
  • 31. Signs and symptoms.  Headaches - Headaches may be experienced due to elevation in blood pressure. Sometimes morning headaches can also be due to hypertension.  Dizziness - Dizziness is often experience by people with high blood pressure. However dizziness cannot always be treated as a symptom of hypertension. If dizziness is experienced it is always wise to consult a medical practitioner.  Heart pain  Palpitations  Nosebleeds - Nosebleeds without particular reason might be a symptom of high blood pressure. It is better to check the blood pressure in such cases.  Difficulty in breathing  Tinnitus (ringing or buzzing in the ears)  Blurred Vision  Frequent urination
  • 32. Diagnosis  History and physical examination  24-hour ambulatory blood pressure monitors and home blood pressure monitoring  Patterns of Blood Pressure  Based on 24-hour ambulatory BP monitoring and office BP readings, 4 patterns of BP have been described  sustained hypertension, Masked hypertension white coat hypertension , normal dipping pattern
  • 33. Home Blood Pressure Monitoring  Home BP measurement guidelines recommend that a validated device be used to measure BP at home Blood pressure measurements using such validated devices should be taken before an office visit, with at least 2 morning and 2 evening readings everyday for 1 week (but discarding the readings of the first day), which gives a total of 12 BP readings over a week, based on which clinical decisions can be made. Hypertension is defined as a mean home blood pressure of ≥135/85 mmHg. Home blood pressure monitoring provides an inexpensive alternative to 24-hour ambulatory BP monitoring.
  • 34.  The recently released National Institute of Health and Clinical Excellence (NICE) guidelines published in the United Kingdom recommend that a diagnosis of primary hypertension should be confirmed with 24- hour ambulatory blood pressure monitoring or home blood pressure monitoring rather than by relying solely on office blood pressure measurement.
  • 35. laboratoryTests  Renal  Microscopic urinalysis, proteinuria, BUN and/or creatinine   Endocrine  Serum sodium, potassium, calcium, TSH   Metabolic  Fasting blood glucose, HDL, LDL, and total cholesterol, triglycerides
  • 36. Others Electrocardiogram Echo cardiography On physical examination, hypertension may be suspected on the basis of the presence of hypertensive retinopathy detected by examination of the optic fundus found in the back of the eye using ophthalmoscopy
  • 37. Prevention  Maintain normal body weight for adults (e.g. body mass index 20–25 kg/m2)  Reduce dietary sodium intake to <100 mmol/ day (<6 g of sodium chloride or <2.4 g of sodium per day)  Engage in regular aerobic physical activity such as brisk walking (≥30 min per day, most days of the week)  Limit alcohol consumption to no more than 3 units/day in men and no more than 2 units/day in women  Consume a diet rich in fruit and vegetables (e.g. at least five portions per day);  Effective lifestyle modification may lower blood pressure
  • 38. Management of Hypertension Goals of Therapy  The primary goal of therapy of hypertension should be effective control of BP in order to prevent, reverse or delay the progression of complications and thus reduce the overall risk of an individual without adversely affecting the quality of life. Patients should be explained that the lifestyle modifications and drug treatment is generally lifelong and regular drug compliance is important
  • 39. Initiation of therapy  Having assessed the patient and determined the overall risk profile, management of hypertension should proceed as follows:  In low risk patients, it is suggested to institute life style modifications and observe BP for a period of 2-3 months, before deciding whether to initiate drug therapy.  In medium risk patients, institute life style modifications and initiate drug therapy after 2-4 weeks, in case BP remains above 140/90.  In high and very high-risk groups, initiate immediate drug treatment for hypertension and other risk factors in addition to instituting life-style modification
  • 40. Management Me d i c a l M a n a g e m e n t Lifestyle modifications Medications
  • 41. Modification Recommendation Weight reduction Maintain normal body weight (body mass index, 18.4–24.9 kg/m2) Adopt DASH eating plan Consume diet rich in fruits, vegetables, low- fat dairy products, with reduced content of saturated and total fats Dietary sodium reduction Reduce dietary sodium intake to no more than 100 mmol/day (2.4g sodium or 6g sodium chloride) Physical activity Engage in regular aerobic physical activity (e.g., brisk walking) at least 30 min/day, most days of the week Moderation of alcohol consumption Most men: limit consumption to no more than two drinks/day‡ Most women and those who weigh less than normal: no more than one drink/day
  • 42. Adopt DASH (Dietary Approaches to Stop Hypertension  Eating more fruits, vegetables, and low-fat dairy foods  Cutting back on foods that are high in saturated fat, cholesterol, and trans fats  Eating more whole grain products, fish, poultry, and nuts  Eating less red meat (especially processed meats) and sweets  Eating foods that are rich in magnesium, potassium, and calcium
  • 43. DASH diet Food group No. of servings per day Grains and grain products 7 or 8 vegetables 4 or 5 fruits 4or5 Low fat or fat free dairy products 2or 3 Meat, fish, poultry 2 or fewer Nuts, seeds,and dry beans 4 or 5 weekly
  • 44.  Different programs aimed to reduce psychological stress such a biofeedback, relaxation or meditation are advertised to reduce hypertension
  • 45. Principles of drug treatment  Over the past decade, the goals of treatment have gradually shifted from optimal lowering of blood pressure, to patient’s overall well being, control of associated risk factors and protection from future target organ damage  Achieve gradual reduction of blood pressure. Use low doses of antihypertensive drugs to initiate therapy.  Five classes of drugs can be recommended as first line treatment for stage 1-2 hypertension1,2 These include :1) ACE inhibitors, 2) angiotensin II receptor blockers, 3) calcium channel blockers, 4) diuretics and 5) newer β-blockers.  The Blood Pressure Lowering Treatment Trialists’ Collaboration concluded that treatment with any commonly used regimen reduces the risk of total major cardiovascular events and larger reductions in blood pressure produce larger reductions in risk.
  • 46. • Choice of an antihypertensive agent is influenced by age, concomitant risk factors, presence of target organ damage, other co-existing diseases, • socioeconomic considerations, availability of the drug and past experience of the physician. • Combining low doses of two or more drugs having synergistic effect is likely to produce lesser side effects. In 60-70 % of patients, goal blood pressure will be achieved with two or more agents only. • Use of fixed dose formulations should be considered to improve compliance. • Drugs with synergistic effects should be combined pertinently to enhance BP lowering effect so as to achieve target BP. • Use of long acting drugs that provide 24-hour efficacy with once daily administration ensures smooth and sustained control of blood pressure; which in turn is expected to provide greater protection against the risk of major cardiovascular events and target organ damage. Once daily administration also improves patient compliance. • Although antihypertensive therapy is generally lifelong, an effort to decrease the dosage and number of antihypertensive drugs should be considered after effective control of hypertension (step-down therapy). • Due to a greater seasonal variation of temperatures in India, marginal alterations in dosages of drugs may be needed from time to time.
  • 47. Medications  Several classes of medications, collectively referred to as antihypertensive drugs, are currently available for treating hypertension.. .One or more of these blood pressure medicines are often used to treat high blood pressure:  Diuretics are also called water pills. They help your kidneys remove some salt (sodium) from your body. As a result, your blood vessels don't have to hold as much fluid and your blood pressure goes down.
  • 48.  Beta-blockers make the heart beat at a slower rate and with less force.  Angiotensin-converting enzyme inhibitors (also called ACE inhibitors) relax your blood vessels, which lowers your blood pressure.  . Angiotensin II receptor blockers (also called ARBs) work in about the same way as angiotensin-converting enzyme inhibitors
  • 49. .  Calcium channel blockers relax blood vessels by stopping calcium from entering cells. Blood pressure medicines that are not used as often include:  Alpha-blockers help relax your blood vessels, which lowers your blood pressure.  Centrally acting drugs signal your brain and nervous system to relax your blood vessels.  Vasodilators signal the muscles in the walls of blood vessels to relax.
  • 50.  Renin inhibitors, a newer type of medicine for treating high blood pressure, act by relaxing your blood vessels  Renin inhibitors work, as the name would suggest, by inhibiting the activity of renin, the enzyme largely responsible for angiotensin II levels. In clinical trials, renin inhibitors have proven effective in not only lowering blood pressure, but also keeping blood pressure levels steadier throughout the day.One renin inhibitor, aliskiren (Tekturna), was approved by the FDA in 2007. Other drugs in this class are in development
  • 51.
  • 52.
  • 53.  Two new techniques to treat resistant hypertension that are undergoing clinical trials involve baroreceptor activation therapy and renal artery denervation in order to lower blood pressure:  Baroreceptor activation therapy is performed using a Rheos baroreflex hypertension therapy system which is surgically implanted in the subclavicular region. The electrodes connected to this device are attached to the carotid body on each side of the neck. Activation of baroreceptors leads to significant lowering of blood pressure.
  • 54.
  • 55. The renal denervation system  uses a catheter to perform radiofrequency ablation when applied to the lumen of renal arteries through a femoral access. In a study, 153 patients with resistant hypertension (baseline BP of 176/98 + 17/15 mmHg) underwent catheter-based renal sympathetic denervation. Patients experienced a sustained BP reduction averaging 32/14 mmHg at 24 months; 92% had an office blood pressure reduction of >10mmHg and 97% of patients were free of procedure-related Complication
  • 56.
  • 57. Conditions for which clinical trials demonstrate benefit of specific classes of antihypertensive drugs.  Heart Failure . In asymptomatic individuals with demonstrable ventricular dysfunction, ACEIs and BBs are recommended. For those with symptomatic ventricular dysfunction or end-stage heart disease, ACEIs, BBs, ARBs and aldosterone blockers are recommended along with loop diuretics.  Diabetic Hypertension  Combinations of two or more drugs are usually needed to achieve the target goal of <130/80 mmHg. Thiazide diuretics, BBs, ACEIs, ARBs, and CCBs are beneficial in reducing CVD and stroke incidence in patients with diabetes. ACEI- or ARB-based treatments favorably affect the progression of diabetic nephropathy and reduce albuminuria, and ARBs have been shown to reduce progression to macroalbuminuria.
  • 58.  Chronic Kidney Disease: Hypertension appears in the majority of these patients, and they should receive aggressive BP management, often with three or more drugs to reach target BP values of <130/80 mmHg. ACEIs and ARBs have demonstrated favorable effects on the progression of diabetic and nondiabetic renal disease.  Cerebrovascular Disease  The risks and benefits of acute lowering of BP during an acute stroke are still unclear; control of BP at intermediate levels (approximately 160/100 mmHg) is appropriate until the condition has stabilized or improved. Recurrent stroke rates are lowered by the combination of an ACEI and thiazide-type diuretic.
  • 59. Obesity and the metabolic syndrome  Intensive lifestyle modification should be pursued in all individuals with the metabolic syndrome, and appropriate drug therapy should be instituted for each of its components as indicated  Left ventricular hypertrophy Left ventricular hypertrophy (LVH) is an independent risk factor that increases the risk of subsequent CVD. Regression of LVH occurs with aggressive BP management, including weight loss, sodium restriction, and treatment with all classes of antihypertensive agents except the direct vasodilators hydralazine, and minoxidil.
  • 60.  Peripheral arterial disease  Peripheral arterial disease (PAD) is equivalent in risk to IHD. Any class of antihypertensive drugs can be used in most PAD patients. Other risk factors should be managed aggressively, and aspirin should be used.  Hypertension in older persons  Hypertension occurs in more than two-thirds of individuals after age 65.This is also the population with the lowest rates of BP control.Treatment recommendations for older people with hypertension, including those who have isolated systolic hypertension, should follow the same principles outlined for the general care of hypertension
  • 61. Hypertension in pregnancy  Women with hypertension who become pregnant should be followed carefully because of increased risks to mother and fetus. Methyldopa, BBs, and vasodilators are preferred medications for the safety of the fetus.ACEI and ARBs should not be used during pregnancy because of the potential for fetal defects and should be avoided In some patients, preeclampsia may develop into a hypertensive urgency or emergency and may require hospitalization, intensive monitoring, early fetal delivery, and parenteral antihypertensive and anticonvulsant therapy
  • 62. Agent Onset Duration Advantages Disadvantages Nitroprusside Immediate 1-2 minutes Potent, titratable Cyanide, isocyanide Nitroglycerine 2-5 minutes 3-5 minutes Coronary perfusion Tolerance, variable efficacy Fenoldopam <5 minutes 5-10 minutes Renal perfusion Increased intraocular pressure Hydralazine 10-20 minutes 3-8 hours Eclampsia Tachycardia, headache Nicardipine 5-15 minutes 1-4 hours CNS protection Avoid in CHF and cardiac ischemia Enalaprilat 15-30 minutes 6 hours CHF, acute LV failure Avoid in MI Intravenous Agents for Hypertensive Emergencies
  • 63. Complications of hypertension  Hypertension is the most important preventable risk factor for premature death.  Ischemic heart disease  Strokes  Peripheral vascular disease,  Other cardiovascular diseases  , Including heart failure, aortic aneurysms, diffuse atherosclerosis, and pulmonaryembolism
  • 64.  Hypertension is also a risk factor for cognitive impairment and dementia, and chronic kidney disease. Other complications include hypertensive retinopathy and hypertensive nephropathy.  Bleeding from the aorta  Target organ disease,POVD, nephrosclerosis  Hypertensive encephalopathy
  • 65. Nursing management  Assessment  History  Past and present medical history  Family history  Risk factors  symptoms  Physical examination  Checking vital signs
  • 66. Nursing problems  Decreased Cardiac Output related to increased peripheral resistance and arterial stiffneff  Acute Pain secondary to hypertension  Activity Intolerance  Imbalanced Nutrition : more than body requirements  Deficient Knowledge  Ineffective therapeutic regimen
  • 67. Researches  Sesame and rice bran oil can treat high blood pressure and cholesterol, study show Significant blood pressure, cholesterol level reductions Yoga benefits high blood pressure through promoting relaxation of the mind and body. Practicing yoga helps decrease the negative impacts of stress, including tension, shallow breathing and elevated heart rate. It also improves physical strength and flexibility, plus may assist with weight loss